SE465352B - Anvaendning av diltiazem foer framstaellning av ett laekemedel foer behandling av hyperlipidemi - Google Patents

Anvaendning av diltiazem foer framstaellning av ett laekemedel foer behandling av hyperlipidemi

Info

Publication number
SE465352B
SE465352B SE8403042A SE8403042A SE465352B SE 465352 B SE465352 B SE 465352B SE 8403042 A SE8403042 A SE 8403042A SE 8403042 A SE8403042 A SE 8403042A SE 465352 B SE465352 B SE 465352B
Authority
SE
Sweden
Prior art keywords
diltiazem
hyperlipidemia
treatment
medicine
preparation
Prior art date
Application number
SE8403042A
Other languages
English (en)
Swedish (sv)
Other versions
SE8403042L (sv
SE8403042D0 (sv
Inventor
K Takashima
S Nitta
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of SE8403042D0 publication Critical patent/SE8403042D0/xx
Publication of SE8403042L publication Critical patent/SE8403042L/
Publication of SE465352B publication Critical patent/SE465352B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
SE8403042A 1983-06-10 1984-06-06 Anvaendning av diltiazem foer framstaellning av ett laekemedel foer behandling av hyperlipidemi SE465352B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58104691A JPS59231018A (ja) 1983-06-10 1983-06-10 抗脂血剤

Publications (3)

Publication Number Publication Date
SE8403042D0 SE8403042D0 (sv) 1984-06-06
SE8403042L SE8403042L (sv) 1984-12-11
SE465352B true SE465352B (sv) 1991-09-02

Family

ID=14387491

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403042A SE465352B (sv) 1983-06-10 1984-06-06 Anvaendning av diltiazem foer framstaellning av ett laekemedel foer behandling av hyperlipidemi

Country Status (12)

Country Link
JP (1) JPS59231018A (fr)
BE (1) BE899867A (fr)
CH (1) CH661867A5 (fr)
DE (1) DE3419425A1 (fr)
DK (1) DK164021C (fr)
FR (1) FR2547730B1 (fr)
GB (1) GB2141027B (fr)
HK (1) HK45489A (fr)
IT (1) IT1196710B (fr)
NL (1) NL8401793A (fr)
SE (1) SE465352B (fr)
SG (1) SG21089G (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778791A (en) * 1986-05-16 1988-10-18 Tanabe Seiyaku Co., Ltd. Pharmaceutical composition for improving constitution of lipids in blood
JPS63107925A (ja) * 1986-05-23 1988-05-12 Tanabe Seiyaku Co Ltd 動脈硬化症予防・治療剤
AT389446B (de) * 1987-10-08 1989-12-11 Tanabe Seiyaku Co Verwendung eines 8-chlorobenzothiazepins zur herstellung eines arzneimittels
DE3737741A1 (de) * 1987-11-06 1989-05-18 Goedecke Ag Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid
GB9423172D0 (en) * 1994-11-17 1995-01-04 Wellcom Foundation The Limited Hypolipidemic benzothiazepines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
JPS58208222A (ja) * 1982-05-28 1983-12-03 Japan Found Cancer 抗腫瘍剤効果増強剤
JPS5970611A (ja) * 1982-10-15 1984-04-21 Tanabe Seiyaku Co Ltd 医薬組成物

Also Published As

Publication number Publication date
JPS6317810B2 (fr) 1988-04-15
NL8401793A (nl) 1985-01-02
BE899867A (fr) 1984-10-01
CH661867A5 (de) 1987-08-31
IT8467596A1 (it) 1985-12-08
IT1196710B (it) 1988-11-25
DK284084A (da) 1984-12-11
DK284084D0 (da) 1984-06-08
FR2547730A1 (fr) 1984-12-28
HK45489A (en) 1989-06-16
GB8414498D0 (en) 1984-07-11
SE8403042L (sv) 1984-12-11
JPS59231018A (ja) 1984-12-25
SG21089G (en) 1990-01-26
DE3419425A1 (de) 1984-12-13
DE3419425C2 (fr) 1989-06-08
GB2141027B (en) 1986-10-22
IT8467596A0 (it) 1984-06-08
FR2547730B1 (fr) 1987-11-13
DK164021B (da) 1992-05-04
SE8403042D0 (sv) 1984-06-06
GB2141027A (en) 1984-12-12
DK164021C (da) 1992-09-28

Similar Documents

Publication Publication Date Title
DE3879080T2 (de) Pharmazeutische matrix mit verzoegerter freisetzung und verfahren.
KR0164435B1 (ko) 비만증 치료용 약제학적 조성물
US4268524A (en) Method of treating abnormal lipoprotein ratios with acylcarnitine
SK2612002A3 (en) Pharmaceutical formulation containing benzamide derivative with improved solubility and oral absorptivity
US6566400B1 (en) Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants
SE465352B (sv) Anvaendning av diltiazem foer framstaellning av ett laekemedel foer behandling av hyperlipidemi
US3144387A (en) Anti-inflammatory compositions
AU666992B2 (en) Pharmaceutical composition for preventing or treating arteriosclerosis
KR860006265A (ko) 9,10-디하이드로 에르고트 알카로이드를 함유하는 서방성 제재의 제조방법
JPS62106016A (ja) 免疫抑制剤
FI89004B (fi) Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat
EP0600582A1 (fr) Traitement de dystrophie musculaire
Upadhyay et al. Studies on Formulation and optimization of Gastro Retentive multi-Particulates of Glibenclamide and Metformin hydrochloride for the treatment of Type II Diabetes mellitus using Gelucire: A Review
JPS5938207B2 (ja) 腎疾患治療剤
US4311694A (en) Amorphous coprecipitates of 4-(monoalkylamino) benzoic acid and derivatives and certain water-soluble materials
JPS6137731A (ja) グアバ葉エキスを有効成分とする経口糖尿病薬
RU2141314C1 (ru) Противовирусный препарат "амиксин" и способ его получения
US20070082903A1 (en) Remedy for rheumatoid arthritis
RU2002115814A (ru) Лечение системной красной волчанки с помощью дегидроэпиандростерона
JPS58140017A (ja) 心不全治療剤
JP3186365B2 (ja) 肝疾患治療薬
JPH03287531A (ja) 膵炎治療薬
EP1941910A1 (fr) Forme pharmaceutique destinee au traitement de cas aigus et d'exacerbations chez des patients souffrant de polyarthrite rhumatoide et de troubles aigus associes
JPH03232870A (ja) チオアミド化合物
JPS6360926A (ja) 感冒薬

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8403042-8

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8403042-8

Format of ref document f/p: F